Publication | Closed Access

Sirolimus in patients with clinically active systemic lupus erythematosus resistant to, or intolerant of, conventional medications: a single-arm, open-label, phase 1/2 trial

RheumatologyAutoimmune DiseaseSystemic Lupus Erythematosus TreatmentLupusSystemic TreatmentLupus NephritisImmunologyClinical TrialsPharmacotherapyImmunotherapyMedicineConventional Medications